Certara, Inc. Corrects Q2 2026 Earnings Presentation Misstatement

What Happened On August 4, 2026, Certara, Inc. (CERT) hosted its Q2 2026 earnings call and posted its Q2 2026 earnings presentation. During the call and in the original presentation, the company misstated the 2025 adjusted EBITDA for its recently divested Regulatory and Medical Writing business by saying it had “generated approximately $17 million of adjusted EBITDA in 2025 excluding unallocated overhead costs.” The company corrected that the $17 million figure should have been described as including unallocated overhead costs. The 2025 adjusted EBITDA for that business excluding unallocated corporate expense that will remain with Certara is approximately $23 million. An updated presentation has been posted at ir.certara.com under “Financials & Filings—Quarterly Results.” The clarification does not affect previously reported financial results, year-over-year comparisons, or Certara’s 2026 Financial Outlook.

Key Details

• Date of disclosure: August 4, 2026 (earnings call and original presentation); 8-K filed Aug 7, 2026.
• Misstated phrase: quoted as “$17M ... excluding unallocated overhead” but should have been “$17M ... including unallocated overhead.”
• Relevant figures: $17 million (including unallocated overhead); ~$23 million (excluding unallocated corporate expenses).
• Updated presentation posted on Certara’s investor site; company says no impact on reported results or 2026 outlook.

Why It Matters This is a clarification about how adjusted EBITDA for a recently divested unit was presented — whether certain corporate overheads were included or excluded. For investors, the distinction matters when comparing business-level profitability or when modeling pro forma financials, but Certara states the correction does not change its reported quarterly results, year-over-year comparisons, or its 2026 outlook. Review the updated presentation if you need the corrected breakdown for your analysis.